Lv1
20 积分 2023-02-19 加入
Triggering ferroptosis to tackle cancer
5天前
已关闭
Decoding TNBC architecture
5天前
已完结
Decoding ferroptosis for cancer therapy
5天前
已完结
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
25天前
已完结
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
2个月前
已完结
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
2个月前
已完结
Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
3个月前
已完结
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
3个月前
已完结
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
4个月前
已完结
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
